thoughts on these estimates, before EPS results? NYSE:TARO, NYSE:WLL, NYSE:EBS, NASDAQ:TBBK

0
8
Financial statistics, accountant, bill calculation

TARO PHARMACEUTICAL INDUSTRIES (NYSE:TARO) EARNINGS INFORMATION (NYSE:TARO)

Taro Pharmaceutical Industries last released its earnings data on July 29th, 2020. The reported ($11.37) EPS for the quarter, missing the consensus estimate of $1.16 by $12.53. The company had revenue of $117.63 million for the quarter, compared to analyst estimates of $158.35 million. Taro Pharmaceutical Industries has generated $6.35 earnings per share over the last year. Taro Pharmaceutical Industries has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, November 2nd, 2020 based off prior year’s report dates.

HOW HAS TARO PHARMACEUTICAL INDUSTRIES’ STOCK BEEN IMPACTED BY COVID-19 (CORONAVIRUS)? (NYSE:TARO)

Taro Pharmaceutical Industries’ stock was trading at $64.44 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TARO shares have increased by 0.9% and is now trading at $65.01.

WHITING PETROLEUM (NYSE:WLL) EARNINGS INFORMATION (NYSE:WLL)

Whiting Petroleum last issued its quarterly earnings data on May 7th, 2020. The oil and gas exploration company reported ($1.53) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.78) by $0.75. The company earned $244.85 million during the quarter, compared to analysts’ expectations of $301.79 million. Whiting Petroleum has generated ($0.86) earnings per share over the last year.

HOW HAS WHITING PETROLEUM’S STOCK BEEN IMPACTED BY COVID-19 (CORONAVIRUS)? (NYSE:WLL)

Whiting Petroleum’s stock was trading at $0.8217 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, WLL shares have decreased by 5.1% and is now trading at $0.78.

EMERGENT BIOSOLUTIONS (NYSE:EBS) EARNINGS INFORMATION (NYSE:EBS)

Emergent Biosolutions last posted its quarterly earnings results on July 30th, 2020. The biopharmaceutical company reported $1.98 EPS for the quarter, beating the consensus estimate of $0.53 by $1.45. The company earned $394.70 million during the quarter. Emergent Biosolutions has generated $2.91 earnings per share over the last year and currently has a price-to-earnings ratio of 34.7.

HOW HAS EMERGENT BIOSOLUTIONS’ STOCK BEEN IMPACTED BY COVID-19 (CORONAVIRUS)? (NYSE:EBS)

Emergent Biosolutions’ stock was trading at $53.03 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, EBS stock has increased by 109.8% and is now trading at $111.24.

BANCORP (NASDAQ:TBBK) EARNINGS INFORMATION (NASDAQ:TBBK)

Bancorp last announced its quarterly earnings data on July 30th, 2020. The bank reported $0.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.07. The company earned $70.61 million during the quarter, compared to analysts’ expectations of $62.46 million. Bancorp has generated $1.06 earnings per share over the last year and currently has a price-to-earnings ratio of 9.8.

HOW HAS BANCORP’S STOCK BEEN IMPACTED BY COVID-19 (CORONAVIRUS)? (NASDAQ:TBBK)

Bancorp’s stock was trading at $8.90 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TBBK stock has increased by 6.0% and is now trading at $9.43.